The Use of Wearable Technology to Acquire Signals for COPD Research
Acquisition of Physiological Signals With a Wearable Technology to Assist on Research Aiming to Improve Early Identification of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)
1 other identifier
observational
63
1 country
1
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition which affects approximately 3 million people in the UK and 210 million worldwide. The disease is characterized by progressive air flow obstruction and decline of lung function. COPD is currently the fourth leading cause of death in the world. The main reason for hospitalisations associated with COPD is exacerbations (chest infections or a worsening of the underlying symptoms). Severe COPD exacerbations are the second largest cause of emergency admissions in the UK. Mild and moderate exacerbations can be managed in the community but if they are not identified promptly they may progress to breathlessness and in some patients to respiratory failure. Thus, finding modalities for early detection and diagnosis of exacerbations is clearly a priority for current and future COPD research. However, these still do not exist. The aim of this study will be to acquire acoustic respiratory signals from COPD patients with a small wearable device. These signals will be subsequently used to carry out engineering research with the objective of trying to find "fingerprints" in them which could be early indicators of disease exacerbations. If those "fingerprints" were found, subsequent research could focus on trying to create software methods which, together with the use of a small wearable device, would aim at automatically detecting exacerbations when they are at very early stages- prior to the symptoms being evident to the patient- so that clinical intervention could be triggered, in order to optimize the disease outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 31, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedDecember 14, 2023
December 1, 2023
3 years
July 28, 2020
December 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The primary objective of this work is to acquire acoustic signals from two groups of COPD patients, that can subsequently be used to carry out COPD signal processing research.
Acoustic signals from wearable technology will be collected from stable COPD patients but also patients with an exacerbation of COPD and the signals analysed for changes
Signals will be recorded for a maximum of 4 weeks
Secondary Outcomes (1)
To explore the usability aspects of a small wearable device in the context of COPD patients
2 patient visits lasting a maximum 1 hour.
Eligibility Criteria
Patients with a proven diagnosis of chronic obstructive pulmonary disease
You may qualify if:
- Patients with a diagnosis of COPD (FEV1:FVC \<0.7)
You may not qualify if:
- Age \< 18 or \>80years
- Subjects who are not fluent in English, or who have special communication needs.
- Known allergy to the adhesive dressing.
- For the stable patients, subjects with physical or mental impairments who would not be able to use the new technology on their own.
- Subjects with very loose/saggy skin in the neck area which would unavoidably result in the device swinging if moving the neck.
- Subjects with implantable devices
- Subjects with known sleep disordered breathing
- Subjects with stridor
- Subjects requiring ventilation
- Subjects unable to give consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Free Hospital NHS Foundation Trustlead
- Imperial College Londoncollaborator
- Acurable Ltd.collaborator
Study Sites (1)
Academic Respiratory Department Royal Free Hospital NHS Foundation Trust
London, NW3 2QG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2020
First Posted
July 31, 2020
Study Start
September 1, 2020
Primary Completion
August 31, 2023
Study Completion
August 31, 2023
Last Updated
December 14, 2023
Record last verified: 2023-12